Intolerant Antibodies is a biopharmaceuticals and healthcare company.
Intolerant Antibodies has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in June 2024.
Intolerant Antibodies is headquartered in South San Francisco, United States.
Intolerant Antibodies is a biopharmaceuticals and healthcare company.
Intolerant Antibodies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intolerant Antibodies — Funding & Investors." VCBacked, June 12, 2024, https://www.vcbacked.co/company/intolerant-antibodies. Accessed August 14, 2026.
VCBacked. (2024). Intolerant Antibodies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/intolerant-antibodies
{{cite web |title=Intolerant Antibodies — Funding & Investors |url=https://www.vcbacked.co/company/intolerant-antibodies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated